Let’s face it – underappreciated penny stocks are often unpredictable and come with high risks. The U.S. Securities and Exchange Commission (SEC) even warns investors about the dangers of investing in this area due to factors like volatility and lack of proper price discovery.
However, if you’re willing to take the risk, there are some underappreciated penny stocks worth considering. One example is Gevo (GEVO), a company based in Salt Lake City, Utah that focuses on clean-surfaced nanotechnology therapeutics. The company’s potential in the growing nanotechnology-based drug delivery market could lead to significant growth.
Another underappreciated penny stock to watch is Clene (CLNN), a clinical-stage pharmaceutical company with a market cap of $54.3 million. Analysts have high expectations for the company, rating its shares a strong buy with a $7 price target, which represents a potential return of nearly 1,546%.
It’s important to note that penny stocks can be risky, as they are often targeted by scam artists and market manipulators. As always, do your own research and consider the risks before investing in any underappreciated penny stocks.